Please login to the form below

Not currently logged in
Email:
Password:

STEM

This page shows the latest STEM news and features for those working in and with pharma, biotech and healthcare.

EMA starts review of MorphoSys’ tafasitamab for lymphoma

EMA starts review of MorphoSys’ tafasitamab for lymphoma

grade lymphoma – in adults who are not candidates for a stem cell transplant.

Latest news

More from news
Approximately 15 fully matching, plus 395 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    As governments around the world introduce strict lockdown measures to stem the spread of COVID-19, the pharmaceutical industry has ramped up efforts to develop an effective vaccine targeting the novel

  • The role of women in science and technology The role of women in science and technology

    In fact, there’s still a dearth of young girls opting to take STEM subjects beyond GCSE level. ... paucity of role models on the lack of girls embarking on STEM careers?

  • Novo Nordisk awakens its ‘Sleeping Beauty’ Novo Nordisk awakens its ‘Sleeping Beauty’

    We also have a stem cell platform, gene editing, an exquisite oral platforms and we believe that if we use this range of tools we can completely change the picture in

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    5. Johnson &Johnson. Johnson &Johnson’s inclusion in this list stems from one unfortunate and potentially damaging issue – or rather a series of them – that could come to a head this

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Replenish. Replace. Rejuvenate. Stem cells can generate vital growth factors to naturally reduce inflammation, increase muscle mass, repair joints, grow hair and boost the immune system, replenishing the body. ... The root causes of ageing are being

More from intelligence
Approximately 1 fully matching, plus 58 partially matching documents found.

Latest appointments

  • Industry appointments Industry appointments

    Rogerio Vivaldi leaves Bioverativ buyout to head up Sigilon. US-based biotech Sigilon aiming to deliver stem cell therapies for diabetes is getting a new leader.

  • Weekly industry appointments Weekly industry appointments

    There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Benchmarking company STEM has appointed Simon Doyle as its new vice president of global customer relations and development. ... further drive value to STEM’s clients.

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells.

  • Porterhouse Medical promotes Emma Conran Porterhouse Medical promotes Emma Conran

    Conran has served in medical writing positions at Porterhouse Medical since 2014 and prior to that she was a translational stem cell biology lecturer at King’s College London.

More from appointments
Approximately 3 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 25 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics